Prophylaxis against lipopolysaccharide-induced liver injuries by lipoic acid in rats

Pharmacological Research

Volumn 48, Issue 6, 2003, Pages 585-591

  Suntres, Zacharias E ^a  

^a Operational Medicine Section   (Canada)

Author keywords

Antioxidants; Endotoxemia; Inflammation; Lipoic acid; Oxidative stress

Indexed keywords

ALANINE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRIC OXIDE; PROTEINASE; SODIUM CHLORIDE; THIOCTIC ACID; TOSYLCHLORAMIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; LIPID PEROXIDATION; LIVER; LIVER INJURY; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHLORAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MALE; NITRIC OXIDE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542607416     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00221-4     Document Type: Article

References (40)

1. Jaeschke H., Smith C.W., Clemens M.G., Ganey P.E., Roth R.A. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol. Appl. Pharmacol. 139:1996;213-226.
2. Hewett J.A., Roth R.A. Hepatic and extrahepatic pathology of bacterial lipopolysaccharides. Pharmacol. Rev. 45:1993;381-411.
3. Glaucer M.P., Zanetti G., Baumgartner J.-D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-739.
4. Ruiter D.J., Van Der Meulen J., Brouwer A., Hummel M.J., Mauw B.J., van der Ploeg J.C.et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 45:1981;38-45.
5. Freudenberg MA, Galanos C. Metabolism of LPS in vivo. In: Ryan JL, Morrison DC, editors. Bacterial endotoxic lipopolysaccharides. Boca Raton: CRC Press; 1992. p. 275-94.
6. Weiss S.J. Tissue destruction by neutrophils. New Engl. J. Med. 320:1989;365-379.
7. Biewenga G.P., Haene G.R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29:1997;315-331.
8. Bustamante J., Lodge J.K., Marcocci L., Tritschler H.J., Packer L., Rihn B.H. α-Lipoic acid in liver metabolism and disease. Free Rad. Biol. Med. 24:1998;1023-1039.
9. Packer L. α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drug Metab. Rev. 30:1998;245-275.
10. Suntres Z.E., Shek P.N. Tocopherol liposomes alleviate LPS-induced hepatotoxicities. J. Endotoxin Res. 3:1996;505-512.
11. Gad SC, Weil CS. Statistics for toxicologists. In: Hayes AW, editor. Principles and methods of toxicology. New York: Raven Press; 1994. p. 221-74.
12. Amacher D.E. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul. Toxicol. Pharmacol. 27:1998;119-130.
13. Hirano S. Kinetics and migratory response of lung vascular-associated polymorphonuclear leukocytes following intraperitoneal and intratracheal administration of lipopolysaccharide in mice. Am. J. Physiol. 270:1996;L836-L845.
14. Hubbard RC, Brantly ML, Crystal RG. Proteases. In: Crystal RG, West JB, editors. Lung injury. New York: Raven Press; 1991. p. 3-13.
15. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:1984;10404-10413.
16. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J. Gastroenterol. Hepatol. 15:2000;718-724.
17. Li J., Billiar T.R. Nitric oxide: determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol. 276:1999;G1069-G1073.
18. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
19. Chensue S.W., Terebuh P.D., Remick D.G., Scales W.E., Kunkel S.L. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumour necrosis factor during experimental endotoxemia: kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138:1991;395-402.
20. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192:1990;245-261.
21. Kiemer A.K., Baron A., Gerbes A.L., Vollmar A.M. α-Lipoic acid inhibits LPS-induced production of nitric oxide and TNFα in isolated rat Kupffer cells. J. Hepatol. 32:2000;122.
22. Okada K., Marubayashi S., Fukuma K., Yamada K., Dohi K. Effect of the 21-aminosteroid on nuclear factor-κB activation of Kupffer cells in endotoxin shock. Surg. 127:2000;79-86.
23. Neuschwander-Tetri B.A., Bellezzo J.M., Britton R.S., Fox E.S. Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. Biochem. J. 320:1996;1005-1010.
24. van den Berg R., Haenen G.R., van den Berg H., Bast A. Transcription factor NF-κB as a potential biomarker for oxidative stress. Br. J. Nutr. 86(Suppl 1):2001;S121-S127.
25. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-κB activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
26. Bierhaus A., Chevion S., Chevion M., Hofmann M., Quehenberger P., Illmer T.et al. Advanced glycation end product-induced activation of NF-κB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes. 46:1997;1481-1490.
27. Taylor B.S., Alarcon L.H., Billiar T.R. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry. 63:1998;766-781.
28. Tracey W.R., Tse J., Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272:1995;1011-1015.
29. Marley R., Holt S., Fernando B., Harry D., Anand R., Goodier D.et al. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology. 29:1999;1358-1363.
30. Liang J.F., Akaike T. Inhibition of nitric oxide synthesis in primary cultured mouse hepatocytes by alpha-lipoic acid. Chem. Biol. Interact. 124:2000;53-60.
31. Hur G.M., Ryu Y.S., Yun H.Y., Jeon B.H., Kim Y.M., Seok J.H. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-κB. Biochem. Biophys. Res. Commun. 261:1999;917-922.
32. Rockey D.C., Chung J.J., McKee C.M., Noble P.W. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology. 27:1998;86-92.
33. Burkart V., Koike T., Brenner H.H., Imai Y., Kolb H. Dihydrolipoic acid protects pancreatic islet cells from inflammatory attack. Agents Actions. 38:1993;60-65.
34. Jaeschke H., Farhood A., Fisher M.A. Smith CW: sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1. Shock. 6:1996;351-356.
35. Erzurum S.C., Downey G.P., Doherty D.E., Schwab B. III Mechanisms of lipopolysaccharide-induced neutrophil retention. J. Immunol. 149:1992;154-162.
36. Haenen G.R., Bast A. Scavenging of hypochlorous acid by lipoic acid. Biochem. Pharmacol. 42:1991;2244-2246.
37. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:1984;10404-10413.
38. Kunimoto F., Morita T., Ogawa R., Fujita T. Inhibition of lipid peroxidation improves survival rate of endotoxemic rats. Circ. Shock. 21:1987;15-22.
39. Henson P.M., Johnston R.B. Jr. Tissue injury in inflammation. Oxidants proteinases and cationiuc proteins. J. Clin. Invest. 79:1987;669-674.
40. Keller G.A., West M.A., Cerra F.B., Simmons R.L. Macrophage-mediated modulation of hepatic function in multiple-system failure. J. Surg. Res. 39:1985;555-563.